ISOFLURANE Side Effects

6947260-0 | Cardiac Arrest, Electromechanical Dissociation, Uterine Inversion
on Aug 05, 2010 Female patient from UNITED KINGDOM , 20 years of age, weighting 143.3 lb, was diagnosed with caesarean section and was treated with Isoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), electromechanical dissociation, uterine inversion. Isoflurane dosage: Once, Inhalation. During the same period patient was treated with BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), METACLOPROMIDE (View Metaclopromide Review and Metaclopromide Label ), OXYTOCIN (View Oxytocin Review and Oxytocin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), SODIUM CITRATE (View Sodium Citrate Review and Sodium Citrate Label ).

6762506-X | Becker's Muscular Dystrophy, Cardio-respiratory Arrest, Condition Aggravated, Hyperkalaemia, Rhabdomyolysis
Patient was taking Isoflurane (View Usage). Patient had the following side effects: becker's muscular dystrophy, cardio-respiratory arrest, condition aggravated, hyperkalaemia, rhabdomyolysis on May 27, 2010 from UNITED KINGDOM Additional patient health information: Male patient , child 12 years of age, weighting 116.8 lb, was diagnosed with anaesthesia and. Isoflurane dosage: Maximum Mac Of 1.4. Patient was hospitalized.

6709072-2 | Abdominal Pain, Coagulopathy, Jaundice, Mental Status Changes, Nausea
Adverse event was reported on Apr 30, 2010 by a Female patient taking Isoflurane (View Usage) (Dosage: Unk Unk Intratracheal 039) . Location: UNITED STATES , 55 years of age, weighting 132.3 lb, After Isoflurane was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), coagulopathy, jaundice (What is jaundice?), mental status changes, nausea (What is nausea?). Patient was hospitalized.

6583720-2 | Abdominal Pain, Coagulopathy, Jaundice, Mental Status Changes, Nausea
on Feb 13, 2010 Female patient from UNITED STATES , 55 years of age, weighting 132.3 lb, was treated with Isoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), coagulopathy, jaundice (What is jaundice?), mental status changes, nausea (What is nausea?). Isoflurane dosage: Intratracheal 039. Patient was hospitalized.


6425067-0 | Apnoea, Oxygen Saturation Decreased, Respiratory Arrest, Somnolence
on Oct 29, 2009 Female patient from AUSTRALIA , 39 years of age, was treated with Isoflurane (View Usage). Patient had the following side effects: apnoea, oxygen saturation decreased, respiratory arrest, somnolence. Isoflurane dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ).

6209989-1 | Hyperthermia Malignant
Patient was taking Isoflurane (View Usage). After Isoflurane was administered, patient had the following side effects: hyperthermia malignant on May 29, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 121.3 lb, was diagnosed with jaw operation and. Isoflurane dosage: .

5925269-3 | Haemodynamic Instability
Adverse event was reported on Oct 13, 2008 by a Male patient taking Isoflurane (View Usage) (Dosage: ) was diagnosed with anaesthesia, induction of anaesthesia and. Location: BRAZIL , 13 years of age, Patient experienced the following unwanted or unexpected effects: haemodynamic instability. During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ), OXYGEN (View Oxygen Review and Oxygen Label ).

5735827-7 | Acute Hepatic Failure, Hepatic Necrosis, Hepatotoxicity, Hypotension, Sepsis
on May 08, 2008 Male patient from UNITED STATES , 58 years of age, weighting 164.0 lb, was treated with Isoflurane (View Usage). Patient had the following side effects: acute hepatic failure, hepatic necrosis, hepatotoxicity, hypotension, sepsis (What is sepsis?). Isoflurane dosage: Inhal One Time Use.

5732829-1 | Blood Gases Abnormal, Blood Potassium Increased, Body Temperature Increased, Carbon Dioxide Increased, Cardiac Arrest, Chest Discomfort, Disseminated Intravascular Coagulation, Heart Rate Increased, Infusion Site Haemorrhage
on May 07, 2008 Female patient from UNITED STATES , 18 years of age, was treated with Isoflurane (View Usage). After Isoflurane was administered, patient had the following side effects: blood gases abnormal, blood potassium increased, body temperature increased, carbon dioxide increased, cardiac arrest (What is cardiac arrest?), chest discomfort, disseminated intravascular coagulation, heart rate increased, infusion site haemorrhage. Isoflurane dosage: .

5631252-8 |
Patient was taking Isoflurane (View Usage). on Feb 04, 2008 from UNITED STATES Additional patient health information: Male patient , 27 years of age, . Isoflurane dosage: .

5630255-7 | Cardio-respiratory Arrest
Adverse event was reported on Feb 04, 2008 by a Male patient taking Isoflurane (View Usage) (Dosage: ) . Location: UNITED STATES , 21 years of age, Patient had the following side effects: cardio-respiratory arrest. During the same period patient was treated with FENTANYL CITRATE (FENTANYL CITRATE) INJEC (View Fentanyl Citrate (fentanyl Citrate) Injec Review and Fentanyl Citrate (fentanyl Citrate) Injec Label ), ALPROSTADIL (View Alprostadil Review and Alprostadil Label ), SUCCINYLCHOLINE CHLORIDE (View Succinylcholine Chloride Review and Succinylcholine Chloride Label ), NITRIC OXIDE (View Nitric Oxide Review and Nitric Oxide Label ), PROPOFOL (View Propofol Review and Propofol Label ), PAPAVERINE (PAPAVERINE) (View Papaverine (papaverine) Review and Papaverine (papaverine) Label ).

5485486-6 | Hepatic Failure, Hepatorenal Syndrome
on Oct 10, 2007 Male patient from UNITED STATES , 45 years of age, was diagnosed with anaesthesia and was treated with Isoflurane (View Usage). After Isoflurane was administered, patient had the following side effects: hepatic failure, hepatorenal syndrome. Isoflurane dosage: Inhal.

5389789-5 | Encephalopathy
on Jul 10, 2007 Male patient from UNITED STATES , child 8 years of age, was diagnosed with status asthmaticus, sedation and was treated with Isoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: encephalopathy. Isoflurane dosage: . During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), SALBUTAMOL (Not Reported) (View Salbutamol Review and Salbutamol Label ), TERABUTAMINE (Not Reported) (View Terabutamine Review and Terabutamine Label ), ISOPRENALINE HCL (Not Reported) (View Isoprenaline Hcl Review and Isoprenaline Hcl Label ), MAGNESIUM SULFATE (Not Reported) (View Magnesium Sulfate Review and Magnesium Sulfate Label ), IPRATROPIUM BROMIDE (Not Reported) (View Ipratropium Bromide Review and Ipratropium Bromide Label ), METHYLPREDNISOLONE (2-4 Mg/kg) (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

4889223-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Jaundice
Patient was taking Isoflurane (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, jaundice (What is jaundice?) on Jan 23, 2006 from UNITED STATES Additional patient health information: Male patient , 69 years of age, . Isoflurane dosage: .

4713140-4 | Blood Creatine Phosphokinase Increased, Hepatic Enzyme Increased
Adverse event was reported on Jul 12, 2005 by a Male patient taking Isoflurane (View Usage) (Dosage: ) . Location: UNITED STATES , 46 years of age, After Isoflurane was administered, patient had the following side effects: blood creatine phosphokinase increased, hepatic enzyme increased. During the same period patient was treated with SUCCINYLCHOLINE (View Succinylcholine Review and Succinylcholine Label ).

4712886-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
on Jul 12, 2005 Male patient from UNITED STATES , 60 years of age, weighting 163.1 lb, was diagnosed with heart transplant (What is heart transplant?), renal transplant and was treated with Isoflurane (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased. Isoflurane dosage: Other. During the same period patient was treated with SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SIMULECT (View Simulect Review and Simulect Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), KETAMINE (View Ketamine Review and Ketamine Label ), SUCCINYLCHOLINE (View Succinylcholine Review and Succinylcholine Label ), NIMBEX (View Nimbex Review and Nimbex Label ).

4660478-5 | Blood Creatine Phosphokinase Increased, Blood Potassium Increased, Hyperthermia
on May 11, 2005 Male patient from , weighting 15.43 lb, was diagnosed with heart disease congenital and was treated with Isoflurane (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, blood potassium increased, hyperthermia. Isoflurane dosage: .

4556390-2 | Hepatocellular Damage
Patient was taking Isoflurane (View Usage). After Isoflurane was administered, patient had the following side effects: hepatocellular damage on Aug 19, 2004 from Additional patient health information: Male patient , 59 years of age, was diagnosed with anaesthesia and. Isoflurane dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

4556389-6 | Hepatic Necrosis
Adverse event was reported on Aug 06, 2004 by a Female patient taking Isoflurane (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: , 54 years of age, Patient experienced the following unwanted or unexpected effects: hepatic necrosis. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), ATTRACURIM (View Attracurim Review and Attracurim Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), DIAMORPHINE (View Diamorphine Review and Diamorphine Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

4556388-4 | Hyperthermia Malignant
on Mar 09, 2004 Male patient from , 50 years of age, was diagnosed with anaesthesia and was treated with Isoflurane (View Usage). Patient had the following side effects: hyperthermia malignant. Isoflurane dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), PROPOFOL (View Propofol Review and Propofol Label ), ROCURONIUM (View Rocuronium Review and Rocuronium Label ), OXYGEN (View Oxygen Review and Oxygen Label ).